STEVE ASELAGE - Director at Travere Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
TVTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by STEVE ASELAGE since 14 Feb 2025

Holdings reported by STEVE ASELAGE for Travere Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 146,919 $1,316,394 $8.96 11 May 2022 Direct
Employee stock option (right to buy) 70,000 05 Nov 2021 Direct Common Stock

Transactions reported by STEVE ASELAGE for Travere Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.